Latest Weizmann News

6 April 2016 | Weizmann in Israel, Weizmann in the News

Third cancer drug to use Weizmann patent

A new drug recently approved by the US Food and Drug Administration to treat a specific type of lung cancer, is the third cancer drug on the market that uses...

read more +

30 March 2016 | Weizmann in Israel, Weizmann in the News

New Research confirms anxiety affects perception

Anxiety effects a person’s perception, so they see the world and respond to stimuli differently, new Weizmann Institute of Science research reveals. Recently in the news, the scientific study was...

read more +

22 February 2016 | Weizmann in Israel, Weizmann in the News

Weizmann scientist at core of breakthrough blood cancer therapy

The breakthrough cancer therapy, currently making headlines for a United States study of leukaemia patients, has its origins at the Weizmann Institute of Science, Israel. Using genetically modified T-cells from...

read more +

2 February 2016 | Weizmann in Israel, Weizmann in the News

Not losing weight? It’s probably not the diet

Your weight loss diet may be failing, not because you are doing something wrong, but because your body’s metabolism is not responding as anticipated. Finally the evidence is here, revealed...

read more +